A Dose-Escalation Study of RO5126766 in Patients With Advanced Solid Tumors.

NCT00773526 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
52
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Hoffmann-La Roche